Article Information
History
- May 21, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 21, 2020 - 02:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Saar Shoer*,1,2,
- Tal Karady*,1,2,
- Ayya Keshet*,1,2,
- Smadar Shilo*,1,2,3,
- Hagai Rossman*,1,2,
- Amir Gavrieli1,2,
- Tomer Meir1,2,
- Amit Lavon1,2,
- Dmitry Kolobkov1,2,
- Iris Kalka1,2,
- Anastasia Godneva1,2,
- Ori Cohen,
- Adam Kariv4,
- Ori Hoch4,
- Mushon Zer-Aviv4,
- Noam Castel4,
- Anat Ekka Zohar5,
- Angela Irony5,
- Benjamin Geiger2,
- Dorit Hizi4,
- Varda Shalev5,8,
- Ran Balicer7 and
- Eran Segal1,2,☨
- 1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
- 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
- 3Pediatric Diabetes Unit, Ruth Rappaport Children’s Hospital, Rambam Healthcare Campus, Haifa, Israel
- 4The public knowledge workshop, Tel Aviv, Israel
- 5Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel
- 7Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel
- 8School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- ↵☨Corresponding author email: eran.segal{at}weizmann.ac.il
↵* Equal contribution
Posted May 21, 2020.
Who should we test for COVID-19? A triage model built from national symptom surveys
